
The FDA clearance allows Edesa to expand an ongoing placebo-controlled study of the CXCL10 antibody EB06 to US sites, with topline data expected in the fourth quarter of 2027.
Chicago - Many people have a frightening image of lepers as disfigured people, roaming around colonies. The Bible makes several references to what is now a reportable infectious disease, rarely seen by dermatologists. Still, leprosy does occur in the United States, and dermatologists should be suspicious of it.






